Pegylated interferon alfa 2b and ribavirin for hepatitis C patients who were nonresponders to previous

被引：9
|
作者：
Lawitz, EJ
Bala, NS
Becker, S
Brown, G
Davis, M
Dhar, R
Ganeshappa, KP
Gordon, S
Holtzmuller, K
Jeffries, M
Li, JJ
Monsour, H
Nader, P
Rosenfield, T
Tolman, K
Kadakia, S
机构：
来源：
GASTROENTEROLOGY | 2003年 / 124卷 / 04期
关键词：
D O I：
10.1016/S0016-5085(03)83957-4
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：A783 / A784
页数：2
相关论文
共 50 条
  • [21] Chronic hepatitis C: Treatment of pegylated interferon/ribavirin nonresponders
    Shiffman M.L.
    Current Hepatitis Reports, 2006, 5 (3) : 114 - 120
  • [22] Catatonia Associated with Pegylated Interferon-α 2b and Ribavirin for Hepatitis C
    Quinn, Davin
    Kuchler, Elizabeth
    Deming, Paulina
    Arora, Sanjeev
    PSYCHOSOMATICS, 2012, 53 (04) : 400 - 401
  • [23] The effect of amantadine on sustained virologic response when added to pegylated interferon alfa 2b plus weight based ribavirin in previous nonresponders and relapsers
    Lawitz, EJ
    Harrison, SA
    Cantu, NS
    Kadakia, SC
    Ganeshappa, KP
    Adams, F
    Davis, M
    Sperling, R
    Tsai, N
    Gasic, A
    Kothari, T
    Cox, J
    Sanders, B
    Silverman, B
    Ghandour, E
    Medoff, J
    Prasad, V
    Afdahl, N
    Mailliard, M
    Curry, M
    GASTROENTEROLOGY, 2004, 126 (04) : A697 - A697
  • [24] Response to interferon alfa 2B and ribavirin in Hispanics with hepatitis C.
    Munoz, HJ
    Arroyo, J
    Chinea, B
    Gonzalez, H
    Rodriguez, F
    Toro, D
    Torres, E
    HEPATOLOGY, 2000, 32 (04) : 348A - 348A
  • [25] Response to pegylated interferon α-2b and ribavirin in children with chronic hepatitis C
    Baker, Robert D.
    Dee, Deborah
    Baker, Susan S.
    JOURNAL OF CLINICAL GASTROENTEROLOGY, 2007, 41 (01) : 111 - 114
  • [26] Peginterferon alfa-2b and Ribavirin: Effective in Patients With Hepatitis C Who Failed Interferon alfa/Ribavirin Therapy
    Poynard, Thierry
    Colombo, Massimo
    Bruix, Jordi
    Schiff, Eugene
    Terg, Ruben
    Flamm, Steven
    Moreno-Otero, Ricardo
    Carrilho, Flair
    Schmidt, Warren
    Berg, Thomas
    McGarrity, Thomas
    Heathcote, E. Jenny
    Goncales, Fernando
    Diago, Moises
    Craxi, Antonio
    Silva, Marcelo
    Bedossa, Pierre
    Mukhopadhyay, Pabak
    Griffel, Louis
    Burroughs, Margaret
    Brass, Clifford
    Albrecht, Janice
    GASTROENTEROLOGY, 2009, 136 (05) : 1618 - 1628
  • [27] Interleukin-2 Plus Ribavirin Versus Interferon-α-2b Plus Ribavirin in Patients with Chronic Hepatitis C Who Did Not Respond to Previous Interferon-α-2b Treatment
    Mariano Malaguarnera
    Giovanni Pistone
    Sergio Neri
    Marcello Romano
    Alfio Brogna
    Salvatore Musumeci
    BioDrugs, 2004, 18 : 407 - 413
  • [28] Interleukin-2 plus ribavirin versus interferon-α-2b plus ribavirin in patients with chronic hepatitis C who did not respond to previous interferon-α-2b treatment
    Malaguarnera, M
    Pistone, G
    Neri, S
    Romano, M
    Brogna, A
    Musumeci, S
    BIODRUGS, 2004, 18 (06) : 407 - 413
  • [29] Early prediction of nonresponders to treatment with interferon alpha 2B and Ribavirin in patients with chronic hepatitis C.
    Liu, LWC
    Tomlinson, G
    Mazulli, T
    Heathcote, J
    HEPATOLOGY, 2000, 32 (04) : 357A - 357A
  • [30] Evaluation of retinopathy in patients with hepatitis C on pegylated interferon alfa-2b and ribavirin: An interim analysis
    Sheinbaum, AJ
    Winn, JM
    Esrason, KT
    GASTROENTEROLOGY, 2003, 124 (04) : A776 - A776
12345